We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cynapsus Therapeutics Inc. (MM) | NASDAQ:CYNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 40.4805 | 20.12 | 40.54 | 0 | 01:00:00 |
Cyngn (or the “Company”) (NASDAQ: CYN), a developer of innovative autonomous driving software solutions for industrial and commercial enterprises, today announced that Lior Tal, CEO, Ben Landen, Vice President of Business Development, and Don Alvarez, CFO, are scheduled to present virtually at the Cowen 2nd Annual Mobility Disruption Conference on Thursday, March 3, 2022, at 1:30 p.m. PT/4:30 p.m. ET. The live webcast of the presentation can be accessed at the “Events & Presentations” page of Cyngn’s Investor Relations website by clicking here.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220219005006/en/
Cyngn management will present virtually at the upcoming Cowen Mobility Disruption Conference. Source: Cyngn
Management will also be participating in virtual one-on-one and small group meetings at the conference, which takes place March 2-4, 2022. Those interested in meeting with management may contact Cyngn’s Investor Relations representative listed below.
About Cyngn
Cyngn is an autonomous vehicle technology company that is focused on addressing industrial uses for autonomous vehicles. Cyngn believes that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbents, and high upfront investment requirements. Cyngn addresses these challenges with its Enterprise Autonomy Suite, which includes DriveMod (modular industrial vehicle autonomous driving software), Cyngn Insight (customer-facing software suite for monitoring/managing AV fleets and aggregating/analyzing data), and Cyngn Evolve (internal toolkit that enables Cyngn to leverage data from the field for artificial intelligence, simulation, and modeling).
To learn more, please visit https://cyngn.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220219005006/en/
Carolyne Sohn Vice President, The Equity Group csohn@equityny.com (415) 568-2255
1 Year Cynapsus Therapeutics Inc. Chart |
1 Month Cynapsus Therapeutics Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions